World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
87
Citations
27100
World Ranking
1211
National Ranking
106

Medicine

D-Index
87
Citations
27111
World Ranking
13669
National Ranking
1271

Richard S. Tedder publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard S. Tedder sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 388 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard S. Tedder D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard S. Tedder sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 87 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard S. Tedder is affiliated with King's College London in the United Kingdom. Their research primarily spans the field of Medicine, with a particular focus on Infectious Diseases. Additional areas of study include Epidemiology, Hepatology, Neurology, and Modeling and Simulation.

Their work concentrates on topics related to SARS-CoV-2 and COVID-19 research, including clinical studies and detection methods. Other main research interests cover long-term effects of COVID-19, COVID-19 epidemiological studies, hepatitis B virus studies, and respiratory viral infections research.

Notable recent papers by Richard S. Tedder include:

  • Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts, 2022, Nature Communications
  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study, 2021, The Lancet Microbe
  • Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19, 2021, Science Immunology
  • Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study, 2021, The Lancet Respiratory Medicine
  • Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK, 2021, The Lancet Respiratory Medicine

Frequent co-authors collaborating with Tedder include:

  • Malcolm G. Semple (35 publications)
  • J. Kenneth Baillie (33 publications)
  • Myra O. McClure (32 publications)
  • Peter Openshaw (32 publications)
  • Samreen Ijaz (27 publications)

Research contributions have been published in multiple venues, with several recurring outlets such as:

  • bioRxiv (Cold Spring Harbor Laboratory) - 8 publications
  • Scientific Reports - 4 publications
  • The Lancet Respiratory Medicine - 3 publications
  • Journal of Infection - 3 publications
  • The Journal of Infectious Diseases - 3 publications

Best Publications

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

    D Whitby;C Boshoff;T Hatzioannou;R.A Weiss

  • Slim disease: a new disease in Uganda and its association with HTLV-III infection.

    D. Serwadda;N.K. Sewankambo;J.W. Carswell;A.C. Bayley

  • Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

    G. R. Simpson;T. F. Schulz;D. Whitby;P. M. Cook

  • Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

    J.A. Garson;R.S. Tedder;M. Briggs;P. Tuke

  • Persistent carriage of hepatitis E virus in patients with HIV infection.

    Harry R. Dalton;Richard P. Bendall;Frances E. Keane;Richard S. Tedder

  • Hepatitis E virus in blood components: a prevalence and transmission study in southeast England

    Patricia E Hewitt;Samreen Ijaz;Su R Brailsford;Su R Brailsford;Rachel Brett

  • Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.

    Robin A. Weiss;Paul R. Clapham;Rachanee Cheingsong-Popov;Angus G. Dalgleish

  • Hepatitis B transmission from contaminated cryopreservation tank

    R.S Tedder;M.A Zuckerman;N.S Brink;A.H Goldstone

  • Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

    Unknown

  • Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.

    Richard J. C. Gilson;Anna E. Hawkins;Michael R. Beecham;Emma Ross

  • ACUTE ENCEPHALOPATHY COINCIDENT WITH SEROCONVERSION FOR ANTI-HTLV-III

    C. A. Carne;Ann Smith;S. G. Elkington;F. E. Preston

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

    Clark D Russell;Cameron J Fairfield;Thomas M Drake;Lance Turtle

  • A NOVEL LYMPHOTROPIC HERPESVIRUS

    R.S. Tedder;Moya Briggs;C.H. Cameron;R. Honess

  • PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN

    R Cheingsong-Popov;R.A Weiss;A Dalgleish;R.S Tedder

  • The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors.

    Hoe Nam Leong;Philip W. Tuke;Richard S. Tedder;Aysha Begum Khanom

  • Enhanced detection by PCR of hepatitis C virus RNA.

    Jeremy A. Garson;Christopher J. Ring;Philip W. Tuke;Richard S. Tedder

  • Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates

    J A Garson;P W Tuke;M Makris;M Briggs

  • HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN TWO COHORTS OF HOMOSEXUAL MEN: NEUTRALISING SERA AND ASSOCIATION OF ANTI-GAG ANTIBODY WITH PROGNOSIS

    Unknown

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients.

    RN Gunson;D Shouval;M Roggendorf;H Zaaijer

  • Human herpesvirus 6 in salivary glands

    J.D. Fox;M. Briggs;P.A. Ward;R.S. Tedder

  • Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

    Stephen R Knight;Antonia Ho;Riinu Pius;Iain Buchan

Frequent Co-Authors

Samreen Ijaz
Samreen Ijaz Public Health England
Jeremy A. Garson
Jeremy A. Garson University College London
Clive Loveday
Clive Loveday University College London
Robert F. Miller
Robert F. Miller University College London
Wolfgang Preiser
Wolfgang Preiser Stellenbosch University
William A. Paxton
William A. Paxton University of Liverpool
Georgios Pollakis
Georgios Pollakis University of Liverpool
Robin A. Weiss
Robin A. Weiss University College London
Thomas F. Schulz
Thomas F. Schulz Hannover Medical School
Richard Gilson
Richard Gilson University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare careers often require advanced nursing qualifications. Many professionals pursue a doctor of nursing practice salary aware that this degree can open doors to specialized roles and leadership positions in clinical settings.

Transitioning from family nursing to more specialized fields, earning an acute care nurse practitioner certification is key for those seeking to work closely with immunocompromised patients or manage complex acute illnesses.

For quicker entry into the profession, aspirants might consider enrolling in an accelerated nurse practitioner program. These programs are designed for faster completion without compromising the depth of nursing and clinical knowledge needed in immunology-related careers.

Additionally, those without formal nursing backgrounds can explore online RN programs for non nurses. These programs provide foundational nursing education and can be a stepping stone to advanced degrees, ensuring a robust understanding of immunological principles within patient care.

Best Scientists Citing Richard S. Tedder

Trending Scientists

Recently Published Articles